Physician profile
Jayant Khitha
NPI 1184829475
$7,706.94
in general payments reported to CMS, 2019-2025
15 companies · $1,925 in 2025
The $1,925 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2021: $932 · 2022: $1,001 · 2023: $1,010 · 2024: $2,144 · 2025: $1,925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,294 · Travel and Lodging: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,293.92 |
| Travel and Lodging | $784.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,141.26 | 2021-2025 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $1,748.97 | 2021-2025 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $1,081.11 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $945.37 | 2022-2025 | Amplatzer Amulet, Navitor, Amplatzer Talisman |
| Boston Scientific Corporation | $659.76 | 2019-2025 | Watchman Access System, Watchman Flx |
| Medtronic Vascular, INC. | $181.88 | 2019 | |
| Zoll Circulation INC | $148.75 | 2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Cvrx, INC. | $147.66 | 2025 | Barostim Neo System |
| Abiomed | $144.42 | 2025 | |
| Heartflow, INC. | $136.02 | 2019 | |
| Shockwave Medical, INC | $111.29 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $99.95 | 2019 | |
| Biotronik INC. | $90.70 | 2022 | |
| Penumbra, INC. | $69.80 | 2025 | Indigo System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayant Khitha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.